- Home
- GRF vs EKSO Comparison
GRF vs EKSO Comparison
Compare GRF & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRF | EKSO |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.9M | 37.9M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | GRF | EKSO |
|---|---|---|
| Price | $10.26 | $10.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 2.0K | ★ 70.7K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | N/A | ★ 41.76 |
| EPS | ★ 1.16 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $81.23 |
| Revenue Next Year | N/A | $7.29 |
| P/E Ratio | $8.62 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.86 | $0.23 |
| 52 Week High | $11.85 | $13.50 |
Technical Indicators
Market Signals| Indicator | GRF | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 44.21 |
| Support Level | $9.96 | $9.64 |
| Resistance Level | $11.00 | $10.76 |
| Average True Range (ATR) | 0.18 | 0.87 |
| MACD | -0.05 | -0.19 |
| Stochastic Oscillator | 48.88 | 1.14 |
Price Performance
Historical ComparisonAbout GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.